Clinical Trial Results

Showing: All studies [change]
Condition: Obesity Location: Bowie, Maryland 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
PHASE3INTERVENTIONAL Alexander City, Alabama +4 more
RECRUITING
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
PHASE3INTERVENTIONAL Fairhope, Alabama +4 more
RECRUITING
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Escondido, California +4 more
RECRUITING
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Tuscaloosa, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Spinal Cord Injury Model Systems (SCIMS) - Education Module
NAINTERVENTIONAL Washington D.C., District of Columbia +2 more
RECRUITING
Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
N/AOBSERVATIONAL Washington D.C., District of Columbia +1 more
RECRUITING
How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
NAINTERVENTIONAL Washington D.C., District of Columbia
RECRUITING
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
N/AOBSERVATIONAL Washington D.C., District of Columbia +2 more
RECRUITING
Prebiotic Inulin for Late-Reproductive Individuals
NAINTERVENTIONAL Washington D.C., District of Columbia
RECRUITING
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
PHASE3INTERVENTIONAL Lancaster, California +4 more
RECRUITING
The RESET System Pivotal Clinical Trial (Protocol Revision K)
NAINTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
PHASE3INTERVENTIONAL Guntersville, Alabama +4 more
RECRUITING
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
PHASE3INTERVENTIONAL Dothan, Alabama +4 more
RECRUITING
Tailoring Mobile Health Technology to Reduce Obesity and Improve Cardiovascular Health in Resource-Limited Neighborhood Environments
NAINTERVENTIONAL Bethesda, Maryland
RECRUITING
Filter Trials
Trial Phase
Study Type